Company Quick10K Filing
Cyanotech
10-Q 2020-06-30 Filed 2020-08-11
10-K 2020-03-31 Filed 2020-06-23
10-Q 2019-12-31 Filed 2020-02-11
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-13
10-K 2019-03-31 Filed 2019-07-01
10-Q 2018-12-31 Filed 2019-02-13
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-13
10-K 2018-03-31 Filed 2018-06-15
10-Q 2017-12-31 Filed 2018-02-06
10-Q 2017-09-30 Filed 2017-11-06
10-Q 2017-06-30 Filed 2017-08-10
10-K 2017-03-31 Filed 2017-06-22
10-Q 2016-12-31 Filed 2017-02-07
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-06-23
10-Q 2015-12-31 Filed 2016-02-11
10-Q 2015-09-30 Filed 2015-11-12
10-Q 2015-06-30 Filed 2015-08-07
10-K 2015-03-31 Filed 2015-07-15
10-Q 2014-12-31 Filed 2015-02-12
10-Q 2014-09-30 Filed 2014-11-12
10-Q 2014-06-30 Filed 2014-08-14
10-K 2014-03-31 Filed 2014-06-27
10-Q 2013-12-31 Filed 2014-02-06
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-12
10-K 2013-03-31 Filed 2013-06-24
10-Q 2012-12-31 Filed 2013-02-07
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-10
10-K 2012-03-31 Filed 2012-06-21
10-Q 2011-12-31 Filed 2012-02-09
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-11
10-K 2011-03-31 Filed 2011-06-23
10-Q 2010-12-31 Filed 2011-02-11
10-Q 2010-09-30 Filed 2010-11-10
10-Q 2010-06-30 Filed 2010-08-12
10-K 2010-03-31 Filed 2010-06-24
10-Q 2009-12-31 Filed 2010-02-11
8-K 2020-09-25 Officers, Exhibits
8-K 2020-08-27 Shareholder Vote
8-K 2020-05-05
8-K 2019-08-22
8-K 2019-06-03
8-K 2019-04-26
8-K 2019-04-12
8-K 2019-01-03
8-K 2018-11-30
8-K 2018-11-06
8-K 2018-08-31
8-K 2018-08-27
8-K 2018-04-13
8-K 2018-01-24

Cyanotech Financials

CYAN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Nexeo Solutions (NXEO) 757 11% 9.1 1% 2,179 1,360 4,040 452 19 169 1,533
Innophos Holdings (IPHS) 681 18% 20.0 2% 876 538 759 135 21 49 991
Hawkins (HWKN) 453 18% 9.4 7% 393 164 549 98 27 55 524
OMNOVA Solutions (OMN) 254 23% 10.7 1% 584 524 760 178 6 50 540
Foamix Pharmaceuticals (FOMX) 188 74% -2.8 -70% 82 28 1 1 -57 -57 160
MediWound (MDWD) 118 0% 35 0 0 0 0 118
Natural Alternatives International (NAII) 60 16% 4.0 4% 115 38 131 21 4 8 31
Mannatech (MTEX) 40 80% 1.4 2% 67 42 118 95 1 6 8
China Jo-Jo Drugstores (CJJD) 40 24% -45.8 -3% 87 66 111 26 -3 -0 22
Ocean Bio Chem (OBCI) 31 38% 8.3 7% 39 9 33 12 3 4 31
Cyanotech (CYAN) 19 41% 31.4 -3% 32 17 32 13 -1 1 25
CTI Industries (CTIB) 8 16% -2.5 -16% 33 31 33 5 -5 -4 9
Fuwei Films (FFHL) 7 14% 4.5 -2% 455 258 304 42 -9 -9 -40
Chromadex (CDXC) 0 55% 0.4 -54% 43 16 33 18 -23 -22 -9
Aurora Cannabis (ACB)
Cronos Group (CRON)
HEXO (HEXO)
Aphria (APHA)
Canopy Growth Corporation (CGC)
Happiness Biotech (HAPP) 0% 66 5 0 0 0 0 -15

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash3445544433343332222122211221112111
Accounts Receivable3332344444533443443323223233322222
Inventory3344333444555576667887888910991010111211
PP&E5667891011111212132015212229313232323232323233333333343434
Assets14161719192223292929303030323231323535313131302929303130302930303432
Accounts Payable1112122222233443344444443344444543
Long-Term Debt1111022556655555588787777777766677
Liabilities3334365899991011109101313131414131312121212131313151817
Stockholders' Equity131415161717202021212121212221222222181717171717181918171616151515
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue667677777777799989887108798987710688
Cost of Revenue4344444444454446554556555456556445
Gross Profit2332333333333443333334334442224243
R&D0000000000000000000000000000000000
SG&A2222222232334433333334333333333332
Tax000000000000-10000-00300000000000-0-0-0
Net Income0-4-10-0-0111-1-1-10-1-00
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1120001-00-02-0101-001-001-00010-1-0-1
Cash Investing-0-1-1-1-3-0-4-1-0-1-0-1-1-1-1-1-2-1-0-0-0-0-0-0-0-0-0-0-0
Cash Financing-00-0-02-03-00-0-0-0-00002-0-00-0-0-0-0-0-0100